Research Report
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 28, 2014; 20(48): 18338-18345
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18338
Table 1 Clinical data of the three groups of patients
GroupNumberSex (n)
Age (yr)
(n)MaleFemaleRangemean ± SD
Observation group (neoplastic polyps)Tubular adenoma85543127-6839.2 ± 7.6
Villous adenoma179824-6536.5 ± 11.2
Mixed adenoma1881029-6637.4 ± 10.9
Control group I (colorectal cancer)Tubular adenocarcinoma42241837-7244.6 ± 11.3
Mucinous adenocarcinoma27171034-7040.2 ± 9.6
Papillary adenocarcinoma85333-5841.1 ± 10.3
Other types133045-5248.3 ± 7.1
Control group II (normal)40261422-5534.6 ± 6.3
Table 2 Detection of target gene loci in the blood specimens of the observation group and the control groups I and II
K-RAS-12
K-RAS-13
hMLH1-Va1384Asp
hMSH2-2783C/A
+-+-+-+-
Observation group31170120111090120
Control group I156518621070773
χ215.47629.6700.56810.811
P value0.0000.0000.4510.001
Control group II139040139040
χ20.000-10.486-
P value1.000-0.001-
Table 3 Mutation rates of target genes in tissue specimens of the observation group and the control groups I and II
K-RAS-12
K-RAS-13
hMLH1-Va1384Asp
hMSH2-2783C/A
+-+-+-+-
Observation group71131119191013117
Control group I2159225815651070
χ216.61833.5380.2897.898
P value0.0000.0000.5910.005
Control group II139040139040
χ20.7020.3353.8831.019
P value0.3610.7500.0480.419